Loukadaki Olga, Tournis Symeon, Gazi Sousana
Clinic of Rheumatology.
Laboratory for the Research of Musculoskeletal System "Th. Garofalidis", KAT General Hospital, Kifissia, Athens, Greece.
Mediterr J Rheumatol. 2017 Sep 29;28(3):161-163. doi: 10.31138/mjr.28.3.161. eCollection 2017 Sep.
Pregnancy-lactation osteoporosis (PLO) is a rare condition with most cases appearing during the third trimester of pregnancy or early in the post-partum period, especially in primigravid women. Our knowledge concerning its pathogenesis is scarce although it seems that most women who experience fragility fractures during this period have a pre-existing bone disease which is further burdened by the mechanical and metabolic changes during pregnancy and lactation. Breastfeeding produces an obligatory loss of maternal skeletal mineral which contributes to the decline of bone density. Little is known whether pharmacological treatments exert a beneficial role upon the situation of PLO since there is lack of firm evidence and bone density seems to recumb spontaneously during weaning.
妊娠哺乳期骨质疏松症(PLO)是一种罕见病症,大多数病例出现在妊娠晚期或产后早期,尤其是初产妇。尽管在此期间发生脆性骨折的大多数女性似乎都有预先存在的骨病,且妊娠和哺乳期的机械及代谢变化会使其病情进一步加重,但我们对其发病机制的了解仍然很少。母乳喂养必然会导致母体骨骼矿物质流失,这会促使骨密度下降。由于缺乏确凿证据,且断奶期间骨密度似乎会自行恢复,因此对于药物治疗是否对PLO病情发挥有益作用知之甚少。